Erratum to Â.C. Crespo etal., "Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation" [Neurobiol Aging. 35, 4, (2014), 777-785], doi:10.1016/j.neurobiolaging.2013.10.078;Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation

Neurobiology of Aging

Volumn 35, Issue 4, 2014, Pages 777-785

  Crespo, Ângela C ^a,b   Silva, Bruno ^a   Marques, Liliana ^a,c   Marcelino, Erica ^d   Maruta, Carolina ^d   Costa, Sónia ^e   Timóteo, Ângela ^e   Vilares, Arminda ^a   Couto, Frederico Simões ^d   Faustino, Paula ^a   Correia, Ana Paula ^f   Verdelho, Ana ^d   Porto, Graça ^g   Guerreiro, Manuela ^d   Herrero, Ana ^e   Costa, Cristina ^e   de Mendonça, Alexandre ^d   Costa, Luciana ^a,c   Martins, Madalena ^b,d  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^e EPE   (Portugal)

^f Centro Hospitalar Universitario do Porto   (Portugal)

^g UNIVERSITY OF PORTO   (Portugal)

Author keywords

Alzheimer's disease; Biochemical markers; Gene expression; Genetics; Iron metabolism; Quantitative trait loci (QTL)

Indexed keywords

ACONITATE HYDRATASE; APOLIPOPROTEIN E; BIOLOGICAL MARKER; FERRITIN; FERROPORTIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2;

ACO1 GENE; AGED; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC MARKER; GENETIC RISK; GENETIC TRANSCRIPTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; IRON METABOLISM DISORDER; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC40A1 GENE; TF GENE; TFR2 GENE; TFRC GENE; TRANSFERRIN BLOOD LEVEL; VERY ELDERLY;

ALZHEIMER'S DISEASE; BIOCHEMICAL MARKERS; GENE EXPRESSION; GENETICS; IRON METABOLISM; QUANTITATIVE TRAIT LOCI (QTL);

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD; APOLIPOPROTEINS E; BRAIN; CATION TRANSPORT PROTEINS; FEMALE; HOMEOSTASIS; HUMANS; IRON; IRON REGULATORY PROTEIN 1; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TRANSFERRIN; RISK;

EID: 84891373826     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.026     Document Type: Erratum

References (59)

1. Abboud S., Haile D.J. Anovel mammalian iron-regulated protein involved in intracellular iron metabolism. J.Biol. Chem. 2000, 275:19906-19912. 10.1074/jbc.M000713200.
2. Altamura S., Muckenthaler M.U. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J.Alzheimers Dis. 2009, 16:879-895. 10.3233/jad-2009-1010.
3. An P., Wu Q., Wang H., Guan Y., Mu M., Liao Y., Zhou D., Song P., Wang C., Meng L., Man Q., Li L., Zhang J., Wang F. TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia. Hum. Mol. Genet. 2012, 21:2124-2131. 10.1093/hmg/dds028.
4. Anderson C.P., Shen M., Eisenstein R.S., Leibold E.A. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta 2012, 1823:1468-1483. 10.1016/j.bbamcr.2012.05.010.
5. Armstrong R.A. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease. Folia Neuropathol. 2009, 47:289-299.
6. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457.
7. Bartzokis G., Tishler T.A. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol. Biol. (Noisy-le-grand) 2000, 46:821-833.
8. Benyamin B., McRae A.F., Zhu G., Gordon S., Henders A.K., Palotie A., Peltonen L., Martin N.G., Montgomery G.W., Whitfield J.B., Visscher P.M. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am. J. Hum. Genet. 2009, 84:60-65. 10.1016/j.ajhg.2008.11.011.
9. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23. http://www.nature.com/ng/journal/v39/n1/suppinfo/ng1934_S1.html.
10. Bodovitz S., Falduto M.T., Frail D.E., Klein W.L. Iron levels modulate α-secretase Cleavage of amyloid precursor protein. J.Neurochem. 1995, 64:307-315. 10.1046/j.1471-4159.1995.64010307.x.
11. Bomboi G., Marchione F., Sepe-Monti M., De Carolis A., Bianchi V., Medda E., Pino A., Bocca B., Forte G., D'Ippolito C., Giubilei F. Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease. Ann. Ist. Super. Sanita 2005, 41:205-212.
12. Burns A., Iliffe S. Alzheimer's disease. BMJ 2009, 338:b158. 10.1136/bmj.b158.
13. Bush A.I. The metal theory of Alzheimer's disease. J.Alzheimers Dis. 2013, 33:S277-S281. 10.3233/jad-2012-129011.
14. Castellani R., Moreira P., Liu G., Dobson J., Perry G., Smith M., Zhu X. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochem. Res. 2007, 32:1640-1645. 10.1007/s11064-007-9360-7.
15. Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the [beta]-amyloid precursor protein gene. Nature 1991, 353:844-846.
16. Cho H.-H., Cahill C.M., Vanderburg C.R., Scherzer C.R., Wang B., Huang X., Rogers J.T. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory Protein-1. J.Biol. Chem. 2010, 285:31217-31232. 10.1074/jbc.M110.149161.
17. Clark R.F., Hutton M., Fuldner M., Froelich S., Karran E., Talbot C., Crook R., Lendon C., Prihar G., He C., Korenblat K., Martinez A., Wragg M., Busfield F., Behrens M.I., Myers A., Norton J., Morris J., Mehta N., Pearson C., Lincoln S., Baker M., Duff K., Zehr C., Perez-Tur J., Houlden H., Ruiz A., Ossa J., Lopera F., Arcos M., Madrigal L., Collinge J., Humphreys C., Ashworth A., Sarner S., Fox N., Harvey R., Kennedy A., Roques P., Cline R.T., Philips C.A., Venter J.C., Forsell L., Axelman K., Lilius L., Johnston J., Cowburn R., Viitanen M., Winblad B., Kosik K., Haltia M., Poyhonen M., Dickson D., Mann D., Neary D., Snowden J., Lantos P., Lannfelt L., Rossor M., Roberts G.W., Adams M.D., Hardy J., Goate A. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 1995, 11:219-222.
18. Collingwood J.F., Chong R.K.K., Kasama T., Cervera-Gontard L., Dunin-Borkowski R.E., Perry G., Pósfai M., Siedlak S.L., Simpson E.T., Smith M.A., Dobson J. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J.Alzheimer's Dis. 2008, 14:235-245.
19. Connor J.R., Benkovic S.A. Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann. Neurol. 1992, 32(Suppl):S51-S61.
20. Coon K.D., Myers A.J., Craig D.W., Webster J.A., Pearson J.V., Lince D.H., Zismann V.L., Beach T.G., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Walker D.G., Ravid R., Heward C.B., Rogers J., Papassotiropoulos A., Reiman E.M., Hardy J., Stephan D.A. Ahigh-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J.Clin. Psychiatry 2007, 68:613-618.
21. Coon K.D., Siegel A.M., Yee S.J., Dunckley T.L., Mueller C., Nagra R.M., Tourtellotte W.W., Reiman E.M., Papassotiropoulos A., Petersen F.F., Stephan D.A., Kirsch W.M. Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease. J.Alzheimer's Dis. 2006, 9:225-233.
22. Cornett C.R., Markesbery W.R., Ehmann W.D. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 1998, 19:339-345.
23. Crichton R., Dexter D., Ward R. Brain iron metabolism and its perturbation in neurological diseases. J.Neural Transm. 2011, 118:301-314. 10.1007/s00702-010-0470-z.
24. Desmet F.-O., Hamroun D., Lalande M., Collod-Béroud G., Claustres M., Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009, 37:e67. 10.1093/nar/gkp215.
25. Ding B., Chen K.-M., Ling H.-W., Sun F., Li X., Wan T., Chai W.-M., Zhang H., Zhan Y., Guan Y.-J. Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J.Magn. Reson. Imaging 2009, 29:793-798. 10.1002/jmri.21730.
26. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C., Lux S.E., Pinkus G.S., Pinkus J.L., Kingsley P.D., Palis J., Fleming M.D., Andrews N.C., Zon L.I. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000, 403:776-781.
27. Duce J.A., Tsatsanis A., Cater M.A., James S.A., Robb E., Wikhe K., Leong S.L., Perez K., Johanssen T., Greenough M.A., Cho H.-H., Galatis D., Moir R.D., Masters C.L., McLean C., Tanzi R.E., Cappai R., Barnham K.J., Ciccotosto G.D., Rogers J.T., Bush A.I. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010, 142:857-867.
28. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198. 10.1016/0022-3956(75)90026-6.
29. Gonzalez J.R., Armengol L., Sole X., Guino E., Mercader J.M., Estivill X., Moreno V. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007, 23:644-645. 10.1093/bioinformatics/btm025.
30. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 1992, 31:286-292. 10.1002/ana.410310310.
31. Grünblatt E., Bartl J., Riederer P. The link between iron, metabolic syndrome, and Alzheimer's disease. J.Neural Transm. 2011, 118:371-379. 10.1007/s00702-010-0426-3.
32. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.-C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R.L.C., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Ruther E., Schurmann B., Heun R., Kolsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Gallacher J., Hull M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S.K., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.-H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M.B., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.-F., Tzourio C., Alperovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Bjornsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossu P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435. http://www.nature.com/ng/journal/v43/n5/abs/ng.803.html#supplementary-information.
33. Honda K., Smith M.A., Zhu X., Baus D., Merrick W.C., Tartakoff A.M., Hattier T., Harris P.L., Siedlak S.L., Fujioka H., Liu Q., Moreira P.I., Miller F.P., Nunomura A., Shimohama S., Perry G. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J.Biol. Chem. 2005, 280:20978-20986. 10.1074/jbc.M500526200.
34. Hong M.-G., Reynolds C.A., Feldman A.L., Kallin M., Lambert J.-C., Amouyel P., Ingelsson E., Pedersen N.L., Prince J.A. Genome-wide and gene-based association implicates FRMD6 in Alzheimer's disease. Hum. Mutat. 2012, 33:521-529. 10.1002/humu.22009.
35. House M.J., St.Pierre T.G., Kowdley K.V., Montine T., Connor J., Beard J., Berger J., Siddaiah N., Shankland E., Jin L.-W. Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn. Reson. Med. 2007, 57:172-180. 10.1002/mrm.21118.
36. Huang C.-W., Wang S.-J., Wu S.-J., Yang C.-C., Huang M.-W., Lin C.-H., Cheng I.H. Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease. Am. J. Alzheimer's Dis. Other Demen 2013, 28:75-83. 10.1177/1533317512467674.
37. Hussain R.I., Ballard C.G., Edwardson J.A., Morris C.M. Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans. Neurosci. Lett. 2002, 317:13-16. 10.1016/S0304-3940(01)02403-X.
38. International, A.D. 2010. World Alzheimer Report 2010: The Global Economic Impact of Dementia. London.
39. Kauwe J.S.K., Bertelsen S., Mayo K., Cruchaga C., Abraham R., Hollingworth P., Harold D., Owen M.J., Williams J., Lovestone S., Morris J.C., Goate A.M. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2010, 153B:955-959. 10.1002/ajmg.b.31053.
40. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., Stevens J.C. Practice parameter: diagnosis of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1143-1153. 10.1212/wnl.56.9.1143.
41. Lehmann D.J., Schuur M., Warden D.R., Hammond N., Belbin O., Kölsch H., Lehmann M.G., Wilcock G.K., Brown K., Kehoe P.G., Morris C.M., Barker R., Coto E., Alvarez V., Deloukas P., Mateo I., Gwilliam R., Combarros O., Arias-Vásquez A., Aulchenko Y.S., Ikram M.A., Breteler M.M., van Duijn C.M., Oulhaj A., Heun R., Cortina-Borja M., Morgan K., Robson K., Smith A.D. Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol. Aging 2012, 33:202.e1-202.e13. 10.1016/j.neurobiolaging.2010.07.018.
42. Lleó A., Blesa R., Angelopoulos C., Pastor-Rubio P., Villa M., Oliva R., Bufill E. Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease. J.Neurol. Neurosurg. Psychiatry 2002, 72:820-821. 10.1136/jnnp.72.6.820-a.
43. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
44. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentze M.W., Simpson R.J. Anovel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 2000, 5:299-309. 10.1016/S1097-2765(00)80425-6.
45. Morris C.M., Kerwin J.M., Edwardson J.A. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 1994, 3:267-275.
46. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
47. Naj A.C., Jun G., Beecham G.W., Wang L.-S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S.K., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., George-Hyslop P.S., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.-W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441. http://www.nature.com/ng/journal/v43/n5/abs/ng.801.html#supplementary-information.
48. Nandar W., Connor J.R. HFE gene variants affect iron in the brain. J.Nutr. 2011, 141:729S-739S. 10.3945/jn.110.130351.
49. Pantoni L., Basile A.M., Pracucci G., Asplund K., Bogousslavsky J., Chabriat H., Erkinjuntti T., Fazekas F., Ferro J.M., Hennerici M., O'Brien J., Scheltens P., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Inzitari D. Impact of age-related cerebral white matter changes on the transition to disability - the LADIS study: rationale, design and methodology. Neuroepidemiology 2005, 24:51-62. 10.1159/000081050.
50. Pichler I., Minelli C., Sanna S., Tanaka T., Schwienbacher C., Naitza S., Porcu E., Pattaro C., Busonero F., Zanon A., Maschio A., Melville S.A., Grazia Piras M., Longo D.L., Guralnik J., Hernandez D., Bandinelli S., Aigner E., Murphy A.T., Wroblewski V., Marroni F., Theurl I., Gnewuch C., Schadt E., Mitterer M., Schlessinger D., Ferrucci L., Witcher D.R., Hicks A.A., Weiss G., Uda M., Pramstaller P.P. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum. Mol. Genet. 2011, 20:1232-1240. 10.1093/hmg/ddq552.
51. Rivera-Mancía S., Pérez-Neri I., Ríos C., Tristán-López L., Rivera-Espinosa L., Montes S. The transition metals copper and iron in neurodegenerative diseases. Chem. Biol. Interact. 2010, 186:184-199. 10.1016/j.cbi.2010.04.010.
52. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., Gullans S.R. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J.Biol. Chem. 2002, 277:45518-45528. 10.1074/jbc.M207435200.
53. Sherrington R., Froelich S., Sorbi S., Campion D., Chi H., Rogaeva E.A., Levesque G., Rogaev E.I., Lin C., Liang Y., Ikeda M., Mar L., Brice A., Agid Y., Percy M.E., Clerget-Darpoux F., Piacentini S., Marcon G., Nacmias B., Amaducci L., Frebourg T., Lannfelt L., Rommens J.M., St George-Hyslop P.H. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 1996, 5:985-988. 10.1093/hmg/5.7.985.
54. Silvestri L., Camaschella C. Apotential pathogenetic role of iron in Alzheimer's disease. J.Cell Mol. Med. 2008, 12:1548-1550. 10.1111/j.1582-4934.2008.00356.x.
55. Sipe J.C., Lee P., Beutler E. Brain iron metabolism and neurodegenerative disorders. Dev. Neurosci. 2002, 24:188-196. doi:65701.
56. Soranzo N., Spector T.D., Mangino M., Kuhnel B., Rendon A., Teumer A., Willenborg C., Wright B., Chen L., Li M., Salo P., Voight B.F., Burns P., Laskowski R.A., Xue Y., Menzel S., Altshuler D., Bradley J.R., Bumpstead S., Burnett M.-S., Devaney J., Doring A., Elosua R., Epstein S.E., Erber W., Falchi M., Garner S.F., Ghori M.J.R., Goodall A.H., Gwilliam R., Hakonarson H.H., Hall A.S., Hammond N., Hengstenberg C., Illig T., Konig I.R., Knouff C.W., McPherson R., Melander O., Mooser V., Nauck M., Nieminen M.S., O'Donnell C.J., Peltonen L., Potter S.C., Prokisch H., Rader D.J., Rice C.M., Roberts R., Salomaa V., Sambrook J., Schreiber S., Schunkert H., Schwartz S.M., Serbanovic-Canic J., Sinisalo J., Siscovick D.S., Stark K., Surakka I., Stephens J., Thompson J.R., Volker U., Volzke H., Watkins N.A., Wells G.A., Wichmann H.E., Van Heel D.A., Tyler-Smith C., Thein S.L., Kathiresan S., Perola M., Reilly M.P., Stewart A.F.R., Erdmann J., Samani N.J., Meisinger C., Greinacher A., Deloukas P., Ouwehand W.H., Gieger C. Agenome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 2009, 41:1182-1190. http://www.nature.com/ng/journal/v41/n11/suppinfo/ng.467_S1.html.
57. Torsdottir G., Kristinsson J., Snaedal J., Jóhannesson T. Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's disease. Demen. Geriatr. Cogn. Dis. Extra 2011, 1:366-371.
58. Vural H., Demirin H., Kara Y., Eren I., Delibas N. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J.Trace Elem. Med. Biol. 2010, 24:169-173. 10.1016/j.jtemb.2010.02.002.
59. Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.